O. Jahn

Serum cathepsin K levels are not suitable to differentiate women with chronic bone disorders such as osteopenia and osteoporosis from healthy pre- and postmenopausal women.

H. Amthauer, S. Westphal, W. Halangk, 2012, Maturitas.

Cathepsin K in treatment monitoring following intravenous zoledronic acid.

S. Kropf, Daniela Adolf, S. Klose, 2014, Biomedical reports.